Two Sigma Investments, LP Lava Therapeutics Nv Put Options Transaction History
Two Sigma Investments, LP
- $50.6 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.94MCall Options Held
17.9KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$3.17 Million0.33% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.97MShares$3.02 Million1.97% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$798,4670.29% of portfolio
-
Pathway Financial Advisors LLC103KShares$156,8250.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$99,4500.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $39.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...